Jan 28, 2022, 17:21 PM by

Jan 28, 2022, 17:21 PM by

The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation.

Jan 28, 2022, 17:21 PM by

The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment.

Jan 28, 2022, 17:21 PM by

This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies.

Jan 28, 2022, 17:21 PM by

Jan 28, 2022, 17:18 PM by

Cotiviti’s preeminent risk assessment and predictive modeling tool continues to aid in improving healthcare cost and quality

Jan 28, 2022, 17:18 PM by

In a talk at the World Expo 2020 Dubai on Sunday, Positive Technologies CEO, Denis Baranov spoke about how protecting all assets from all cyberattacks is unrealistic, and suggested that organizations and industries instead take a new approach that specifically focuses on eliminating ‘unacceptable’ risks at every level.

Jan 28, 2022, 17:18 PM by

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of ligand-based pharmacophore model service for scientists to accelerate the drug candidate development process.

Jan 28, 2022, 17:18 PM by

Lipidomics, a division of Creative Proteomics, is committed to providing untargeted lipidomics services, targeted lipidomics services, metabolic flux analysis services, and lipidomics related services for research institutions, biotechnology and pharmaceutical companies. The company continues to accelerate lipidomics research to make contributions in the fields of biopharmaceuticals, population health, the food industry, etc. Creative Proteomics Lipidomics has recently announced the launch of Exosomes Lipidomics Service, which can help scientists understand vesicle biogenesis and function, identify lipid-based biomarkers and unravel their monitoring function in diseases.

Jan 28, 2022, 17:18 PM by

Jan 28, 2022, 17:18 PM by

Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced Disease Cytokine Assays to help researchers obtain higher quality scientific research data.

Jan 28, 2022, 17:18 PM by

Amerigo Scientific introduces Polycaprolactone for research uses.

Jan 28, 2022, 17:18 PM by

STEMart launches chemical characterization services for the medical device industry.

Jan 28, 2022, 17:18 PM by

Domainex Ltd., a leading provider of integrated drug discovery services to life science organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing agreement with Ipsen. The agreement provides an exclusive licence to research, develop, manufacture and commercialise FLIP inhibitors. Domainex has supported the FLIP inhibitor programme from its inception.

Jan 28, 2022, 17:18 PM by

Positive Technologies today issued a new study that outlines the top 10 phishing topics used by cybercriminals throughout 2021, including: • New TV shows and movies • Banking issues • Travel and vacation • Dating • And cryptocurrency investments

Jan 28, 2022, 17:18 PM by

Jan 28, 2022, 17:18 PM by

Jan 27, 2022, 01:00 AM by User Not Found

Bio-IT World | Researchers at Mount Sinai and the University of Colorado are pursuing the possibilities that stem from predicting which COVID-19 patients are most likely to deteriorate over time. The hope is that this ability could help health care professionals more effectively triage patients and pair them with appropriate treatments to improve outcomes.

Jan 26, 2022, 01:00 AM by User Not Found

Bio-IT World | Efforts are underway to create an economy of data contributors and researchers who want to retain ownership of their contribution to longevity research as well as a proportionate share of the downstream profits from any resulting products. The ecosystem, and tokens underpinning it, goes by the name of Rejuve—definitionally, “the process of making somebody young again.”

Jan 25, 2022, 01:00 AM by User Not Found

Bio-IT World | After a decade of methodical preparation, Canada’s Ontario Brain Institute's (OBI) neuroinformatics platform, Brain-CODE, launched its open data sharing feature for global brain disorder research.